Quick Answer
Palomino Laboratories Inc. reported Shares Outstanding of 18.77 million shares for fiscal year 2025.
Palomino Laboratories Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 18.77M | +317.1% |
| 2024 | 4.50M | -10.0% |
| 2023 | 5.00M | +0.0% |
| 2022 | 5.00M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 17.61M | +252.2% | +252.2% |
| June 30, 2025 | 5.00M | +0.0% | +0.0% |
| March 31, 2025 | 5.00M | +0.0% | +11.1% |
| December 31, 2024 | 4.50M | -10.0% | -10.0% |
| September 30, 2024 | 5.00M | +0.0% | +0.0% |
| June 30, 2024 | 5.00M | — | +0.0% |
| March 31, 2024 | 5.00M | — | +0.0% |
| December 31, 2023 | 5.00M | +0.0% | +0.0% |
- Palomino Laboratories Inc. showed an increase of +317.1% in Shares Outstanding compared to the prior fiscal year.
- Over the 2022–2025 period, Palomino Laboratories Inc.’s shares outstanding has grown by 275.4% (from 5.00 million shares to 18.77 million shares).
- The most recent figure is from Palomino Laboratories Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: